Navigation Links
Pregis Announces Extension of Exchange Offer
Date:2/24/2010

DEERFIELD, Ill., Feb. 24 /PRNewswire-FirstCall/ -- Pregis Corporation, a leading international manufacturer, marketer, and supplier of protective packaging products and specialty packaging solutions, today announced the extension of its offer to exchange up to euro 125 million of its Second Priority Senior Secured Floating Rate Notes due 2013 issued in a private placement on October 5, 2009 for an equal principal amount of Second Priority Senior Secured Floating Rate Notes due 2013 that have been registered under the Securities Act of 1933, as amended.  The exchange offer is now scheduled to expire at 12:00 a.m. (midnight), Eastern Time, on February 26, 2010, unless further extended by Pregis.  As of 5:00 p.m., Eastern Time, on February 23, 2010, approximately $98.9 million of the outstanding Second Priority Senior Secured Floating Rate Notes had been tendered in the exchange offer.

Requests for a prospectus and a letter of transmittal in connection with the exchange offer should be directed to the exchange agent, The Bank of New York Mellon Trust Company, N.A., at +44 207 964 4958.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Pregis:

Pregis Corporation is a leading global provider of innovative protective, flexible, and foodservice packaging and hospital supply products. The specialty-packaging leader currently operates 46 facilities in 18 countries around the world.  Pregis Corporation is a wholly owned subsidiary of Pregis Holding II Corporation. For more information about Pregis, visit the Company's web site at www.pregis.com.

Safe Harbor Statement:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by the Company's use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. For a discussion of key risk factors, please see the risk factors disclosed in the Company's annual report, which is available on its website, www.pregis.com. These risks may cause actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Given these risk and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. The Company undertakes no duty to update its forward-looking statements.

SOURCE Pregis Corporation

Back to top

RELATED LINKS
http://www.pregis.com

'/>"/>

SOURCE Pregis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Pregis Announces Third Quarter 2009 Financial Results
2. Pregis Announces Second Quarter 2009 Financial Results
3. Pregis Announces First Quarter 2009 Financial Results
4. Pregis Announces Fourth Quarter and Full Year 2008 Financial Results
5. Pregis Announces Investor Conference Call to Review Fourth Quarter and Full Year 2008 Financial Results
6. Pregis Announces Third Quarter 2008 Financial Results
7. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
8. Pregis Announces Second Quarter 2008 Financial Results
9. Pregis Announces First Quarter 2008 Financial Results
10. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
11. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology: